Adult height and cause-specific death
The Emerging Risk Factors Collaboration. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.
Int J Epidemiol. 2012 [in press] [Epub ahead of print] [PubMed]
Lipids and cardiovascular risk prediction
The Emerging Risk Factors Collaboration. Lipid-related markers and cardiovascular disease prediction.
JAMA. 2012;307:2499-2506. [PubMed]. Additional Details: ERFC reply to correspondence, November 21st, 2012, JAMA.
Interleukin-6 receptor pathways and coronary heart disease
IL6R Genetics Consortium and Emerging Risk Factors Collaboration. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
Lancet. 2012;379:1205-1213. [PubMed]
Quantifying net benefits of alternative prognostic models
The Emerging Risk Factors Collaboration. A framework for quantifying net benefits of alternative prognostic models.
Stat Med. 2012;31:114-130. [PubMed]
Adiposity measures and vascular risk
The Emerging Risk Factors Collaboration. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.
Lancet. 2011;377:1085-95. [PubMed]
Diabetes and cause-specific death
The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death.
N Engl J Med. 2011;364:829-841. [PubMed]
Diabetes and vascular risk
The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
Lancet. 2010;375:2215-2222. [PubMed]
Statistical methods protocol
The Emerging Risk Factors Collaboration. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies.
Int J Epidemiol. 2010;39:1345-1359. [PubMed]
Triglyceride-mediated pathways and coronary disease
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
Lancet. 2010;375:1634-1639. [PubMed]
C-reactive protein concentration and vascular risk
The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Lancet. 2010; 375 (9709):132-40. [PubMed]
Lipids, apolipoproteins and vascular risk
The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease.
JAMA. 2009; 302 (18):1993-2000. [PubMed] 
Tables and figures here
Lipoprotein(a) and vascular risk
The Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and non-vascular mortality.
JAMA. 2009; 302 (4):412-23. [PubMed]
Tables and figures here
Protocol paper
The Emerging Risk Factors Collaboration. Analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular disease.
Eur J Epidemiol. 2007; 22 (12):839-869. [PubMed]
ERFC protocol update is available here